BE809369A - Composes triaziniques - Google Patents

Composes triaziniques

Info

Publication number
BE809369A
BE809369A BE139496A BE139496A BE809369A BE 809369 A BE809369 A BE 809369A BE 139496 A BE139496 A BE 139496A BE 139496 A BE139496 A BE 139496A BE 809369 A BE809369 A BE 809369A
Authority
BE
Belgium
Prior art keywords
triazin
compounds
triazin compounds
Prior art date
Application number
BE139496A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE809369A publication Critical patent/BE809369A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BE139496A 1973-01-04 1974-01-03 Composes triaziniques BE809369A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB55373*[A GB1457873A (en) 1973-01-04 1973-01-04 Imidazotriazines

Publications (1)

Publication Number Publication Date
BE809369A true BE809369A (fr) 1974-07-03

Family

ID=9706420

Family Applications (1)

Application Number Title Priority Date Filing Date
BE139496A BE809369A (fr) 1973-01-04 1974-01-03 Composes triaziniques

Country Status (19)

Country Link
US (1) US3941785A (cs)
JP (1) JPS4995994A (cs)
AT (1) AT336029B (cs)
AU (1) AU474078B2 (cs)
BE (1) BE809369A (cs)
CA (1) CA1005057A (cs)
CH (1) CH618170A5 (cs)
DE (1) DE2364076A1 (cs)
ES (1) ES422001A1 (cs)
FI (2) FI57260C (cs)
FR (1) FR2213058B1 (cs)
GB (1) GB1457873A (cs)
IE (1) IE38681B1 (cs)
IL (1) IL43872A (cs)
LU (1) LU69099A1 (cs)
NL (1) NL7400095A (cs)
NO (1) NO140301C (cs)
SE (1) SE408179B (cs)
ZA (1) ZA739534B (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
US4096257A (en) * 1977-05-23 1978-06-20 American Cyanamid Company Substituted imidazo [1,2-d]-as-triazines
US4107309A (en) * 1977-05-23 1978-08-15 American Cyanamid Company Substituted imidazo[1,2-d]-as-triazines
US4126444A (en) * 1977-11-22 1978-11-21 American Cynamid Company Substituted imidazo (1,5-D)-as-triazin-4-ols, and herbicidal use thereof
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
DD244681A3 (de) * 1985-12-02 1987-04-15 Zeiss Jena Veb Carl Vorrichtung zur positionierung von enden flexibler lichtleitelemente
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
WO2001013953A2 (en) * 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
BR9816155B1 (pt) 1997-11-12 2010-07-27 imidazotriazinonas 2-fenil-substituìdas como inibidores de fosfodiesterase, bem como medicamento e uso farmacêutico compreendendo as mesmas.
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
CN1314811A (zh) 1998-08-26 2001-09-26 史密丝克莱恩比彻姆公司 治疗肺病的方法
ATE348618T1 (de) * 2001-05-09 2007-01-15 Bayer Healthcare Ag Neue verwendung von 2-(2-ethoxy-5-(4-methyl- piperazin-1-sulfonyl)-phenyl)-5-methyl-7-propyl 3h-imidazo(5,1-f)(1,2,4)triazin-4-on
GB0113344D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
DE10130167A1 (de) * 2001-06-22 2003-01-02 Bayer Ag Imidazotriazine
DE10135815A1 (de) 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
DE10230605A1 (de) * 2002-07-08 2004-01-29 Bayer Ag Substituierte Imidazotriazine
DE10230604A1 (de) * 2002-07-08 2004-01-29 Bayer Ag Heterocyclisch substituierte Imidazotriazine
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US7462614B2 (en) * 2003-04-01 2008-12-09 Smithkline Beecham Corporation Imidazotriazine compounds
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
KR20080056250A (ko) * 2005-09-29 2008-06-20 바이엘 헬스케어 아게 비뇨기 장애의 치료를 위한 pde 억제제 및 이들의 조합
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
CA2643199A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
JP2010502722A (ja) * 2006-09-08 2010-01-28 ブレインセルス,インコーポレイティド 4−アシルアミノピリジン誘導体を含む組み合わせ
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2167057A1 (en) * 2007-06-13 2010-03-31 Bayer HealthCare AG Pde inhibitors for the treatment of hearing impairment
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) * 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques

Also Published As

Publication number Publication date
DE2364076A1 (de) 1974-07-18
IL43872A (en) 1979-01-31
IE38681B1 (en) 1978-05-10
FI793137A7 (fi) 1981-01-01
FR2213058A1 (cs) 1974-08-02
NO140301B (no) 1979-04-30
AT336029B (de) 1977-04-12
NO140301C (no) 1979-08-08
IL43872A0 (en) 1974-03-14
JPS4995994A (cs) 1974-09-11
LU69099A1 (cs) 1974-04-02
GB1457873A (en) 1976-12-08
ZA739534B (en) 1974-11-27
CH618170A5 (cs) 1980-07-15
IE38681L (en) 1974-07-04
US3941785A (en) 1976-03-02
ATA2374A (de) 1976-08-15
ES422001A1 (es) 1976-08-01
AU6377473A (en) 1975-06-19
CA1005057A (en) 1977-02-08
NL7400095A (cs) 1974-07-08
FI57260C (fi) 1980-07-10
FR2213058B1 (cs) 1977-07-01
FI57260B (fi) 1980-03-31
SE408179B (sv) 1979-05-21
AU474078B2 (en) 1976-07-15

Similar Documents

Publication Publication Date Title
BE809369A (fr) Composes triaziniques
BE816519A (fr) Composes aotes
BE819116A (fr) Composes polyeniques
SE388554B (sv) Svarv
BE822846A (fr) Composes (1-alkyl-5-nitro-imidazolyl-2-alkyl)-heteroaryliques
BE819117A (fr) Composes polyeniques
BE820848A (fr) Composes triglycidyliques
FI54178B (fi) Foerfaringssaett foer framstaellning av ett foerstyvat isolationselement
BE812672A (fr) Composes heterocycliques
BE823401A (fr) Composes (1-alkyl-5-nitro-imidazolyl-2-alkyl)-heteroaryliques
BE814467A (fr) Composes tetracycliques amino-substitues
BE823625A (fr) Composes heteroxycliques
FI53973C (fi) Foerfarande foer framstaellning av 6-amino-penicillansyra
BE819486A (fr) Composes monoazoiques hydrosolubles
BE822343R (fr) Composes imidazoliques
IT1048168B (it) Composti organostannici
BE822291A (fr) Composes de (1-alkyl-5-nitro-imidazolyl-2-alkyl) pyridyle
FI54813C (fi) Foerfarande foer framstaellning av kortfibrer fraon termoplaster
BE822232A (fr) Composes polycycliques
BE818108A (fr) Phenylglycylcephalosporines substituees
FI53679C (fi) Foerfarande foer framstaellning av skivor av traematerial
BE817590A (fr) Composes trifluoromethyl-amino-aryl-sulfonyliques
BE811006A (fr) Composes anthraquinoniques
BE813003A (fr) Composes tricycliques
BE816698A (fr) Composes phosphoreux